D-blind, placebo-controlled, parallel-arm, multicentre, prospective dose-finding trial of the safety and efficacy of atacicept in subjects with active rheumatoid arthritis who have failed a three month therapeutic trial with a TNFa antagonist due to lack of efficacy.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00430495?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
